Invasive Aspergillosis — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Voriconazole inhibits CYP3A4 and markedly increases Tacrolimus levels
Voriconazole is a potent inhibitor of CYP3A4, CYP2C9, and CYP2C19. It dramatically increases Tacrolimus levels (typically 3-fold or more), risking severe nephrotoxicity and neurotoxicity. When initiating Voriconazole, Tacrolimus dose should be reduced by approximately one-third to one-half, with frequent therapeutic drug monitoring of both drugs. Voriconazole itself requires TDM (target trough 1–5.5 mg/L).
Reference: BNF 2024 – Drug interactions: Voriconazole; BSAC 2022 – Antifungal guidelines